1. Home
  2. FF vs ANIK Comparison

FF vs ANIK Comparison

Compare FF & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$4.11

Market Cap

212.3M

Sector

Industrials

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.70

Market Cap

197.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
ANIK
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
197.6M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
FF
ANIK
Price
$4.11
$14.70
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
376.0K
109.4K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
5.32%
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$7.90
52 Week High
$5.12
$16.24

Technical Indicators

Market Signals
Indicator
FF
ANIK
Relative Strength Index (RSI) 41.15 50.08
Support Level $3.78 $13.81
Resistance Level $4.13 $15.74
Average True Range (ATR) 0.24 0.92
MACD -0.02 -0.05
Stochastic Oscillator 4.19 68.47

Price Performance

Historical Comparison
FF
ANIK

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuels segment sells biodiesel and other petroleum products, with fuels made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment, which generates the majority of revenue, sells products used in the production of agricultural chemicals, including herbicides, as well as coatings and cleaning products such as detergents.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: